Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Sanchez-Guijo, Fermin  [Clear All Filters]
Journal Article
Sanchez-Guijo F, Garcia-Arranz M, López-Parra M, Monedero P, Mata-Martínez C, Santos A, Sagredo V, Álvarez-Avello J-M, Guerrero JEugenio, Pérez-Calvo C, et al. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. 2020:100454.
Gomez-Ruiz V, Blanco JF, Villarón EM, Fidalgo H, López-Parra M, Sanchez-Guijo F. Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial. Stem Cell Res Ther. 2023;14(1):78.
Saccardi R, Putter H, Eikema D-J, Busto MPaula, McGrath E, Middelkoop B, Adams G, Atlija M, Ayuk FAyuketang, Baldomero H, et al. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant. 2023.
Aristizábal JAlejandro, Chandia M, Del Cañizo MConsuelo, Sanchez-Guijo F. [Bone marrow microenvironment in chronic myeloid leukemia: Implications for disease physiopathology and response to treatment.]. Rev Med Chil. 2014;142(5):599-605.
Vives J, Sanchez-Guijo F, Gnecchi M, Zwaginga JJan. Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in Europe. Cytotherapy. 2023.
Ruggeri A, Galimard J-E, Labopin M, Rafii H, Blaise D, Ciceri F, Diez-Martin J-L, Cornelissen J, Chevallier P, Sanchez-Guijo F, et al. Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT. Transplant Cell Ther. 2022.
Preciado S, Muntión S, Corchete LA, Ramos TL, de la Torre AG, Osugui L, Rico A, Espinosa-Lara N, Gastaca I, Díez-Campelo M, et al. The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34 Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability. Stem Cells. 2019.
Greco R, Alexander T, Del Papa N, Müller F, Saccardi R, Sanchez-Guijo F, Schett G, Sharrack B, Snowden JA, Tarte K, et al. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. EClinicalMedicine. 2024;69:102476.
Trento C, Bernardo MEster, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, et al. Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018.
Hernández-Boluda J-C, Pereira A, Alvarez-Larran A, Martín A-A, Benzaquen A, Aguirre L, Mora E, González P, Mora J, Dorado N, et al. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model: Prognostication in myelofibrosis. Biol Blood Marrow Transplant. 2020.
López-Ruano G, Prieto-Bermejo R, Ramos TL, San-Segundo L, Sánchez-Abarca LIgnacio, Sanchez-Guijo F, Pérez-Simón JAntonio, Sánchez-Yagüe J, Llanillo M, Hernández-Hernández Á. PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche. Stem Cell Reports. 2015.
Sanchez-Guijo F, Avendaño-Solá C, Badimon L, Bueren JA, Canals JM, Delgadillo J, Delgado J, Eguizabal C, Fernández-Santos M-E, García-Olmo D, et al. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplant. 2023.
Martínez-Carrasco R, Sánchez-Abarca LIgnacio, Nieto-Gómez C, García EMartín, Sanchez-Guijo F, Argüeso P, Aijón J, Hernández-Galilea E, Velasco A. Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD. Ocul Surf. 2019.
Martí-Chillón G-J, Muntión S, Preciado S, Osugui L, Navarro-Bailón A, González-Robledo J, Sagredo V, Blanco JF, Sanchez-Guijo F. Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome. Clin Transl Med. 2023;13(1):e1163.
Berastegui N, Ainciburu M, Romero JP, Garcia-Olloqui P, Alfonso-Pierola A, Philippe C, Vilas-Zornoza A, San Martin-Uriz P, Ruiz-Hernández R, Abarrategi A, et al. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes. Nat Commun. 2022;13(1):7619.
Roson-Burgo B, Sanchez-Guijo F, Del Cañizo C, Rivas JDe Las. Transcriptomic portrait of human Mesenchymal Stromal/Stem cells isolated from bone marrow and placenta. BMC Genomics. 2014;15(1):910.
Navarro-Bailón A, López-Parra M, Veiga-Vaz Á, Villarón EMaría, Díez-Campelo M, Martín AÁfrica, Pérez-López E, Cabrero M, Vázquez L, López-Corral L, et al. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells. Cytotherapy. 2024.
Ainciburu M, Ezponda T, Berastegui N, Alfonso-Pierola A, Vilas-Zornoza A, San Martin-Uriz P, Alignani D, de Espinosa JLamo, San Julian M, Solas TJiménez, et al. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single cell resolution. Elife. 2023;12.